Compare TMP & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMP | NEOG |
|---|---|---|
| Founded | 1836 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 1989 |
| Metric | TMP | NEOG |
|---|---|---|
| Price | $77.49 | $9.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $74.00 | $10.67 |
| AVG Volume (30 Days) | 54.1K | ★ 4.2M |
| Earning Date | 01-28-2026 | 01-08-2026 |
| Dividend Yield | ★ 3.47% | N/A |
| EPS Growth | ★ 27.02 | N/A |
| EPS | ★ 5.90 | N/A |
| Revenue | $316,920,000.00 | ★ $880,319,000.00 |
| Revenue This Year | $16.28 | N/A |
| Revenue Next Year | $1.90 | $2.00 |
| P/E Ratio | $12.71 | ★ N/A |
| Revenue Growth | ★ 10.67 | N/A |
| 52 Week Low | $54.16 | $3.87 |
| 52 Week High | $77.33 | $12.07 |
| Indicator | TMP | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 65.35 | 73.90 |
| Support Level | $74.74 | $8.93 |
| Resistance Level | $77.01 | $9.78 |
| Average True Range (ATR) | 1.75 | 0.52 |
| MACD | 0.19 | 0.10 |
| Stochastic Oscillator | 99.15 | 77.71 |
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.